Page 129 - GPD-4-2
P. 129

Gene & Protein in Disease                                             Pediatric glioma circadian clock genes



               predicts the prognosis and the response to tumor treating   101. Iwadate Y, Matsutani T, Hirono S, Shinozaki N, Saeki N.
               fields treatment. CNS Neurosci Ther. 2022;28(12):2148-2162.  Transforming growth factor-beta and stem cell markers
                                                                  are highly expressed around necrotic areas in glioblastoma.
               doi: 10.1111/cns.13956
                                                                  J Neurooncol. 2016;129(1):101-107.
            91.  Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses
               of high-grade glioma predict prognosis, delineate a pattern      doi: 10.1007/s11060-016-2145-6
               of disease progression, and resemble stages in neurogenesis.   102. Jin X, Kim LJY, Wu Q,  et al. Targeting glioma stem cells
               Cancer Cell. 2006;9(3):157-173.                    through combined BMI1 and EZH2 inhibition.  Nat Med.
                                                                  2017;23(11):1352-1361.
               doi: 10.1016/j.ccr.2006.02.019
                                                                  doi: 10.1038/nm.4415
            92.  Yu M, Li W, Wang Q, Wang Y, Lu F. Circadian regulator
               NR1D2 regulates glioblastoma cell proliferation and   103. Luo Z, Xia M, Shi W, et al. Human fetal cerebellar cell atlas
               motility. Oncogene. 2018;37(35):4838-4853.         informs medulloblastoma origin and oncogenesis. Nature.
                                                                  2022;612(7941):787-794.
               doi: 10.1038/s41388-018-0319-8
                                                                  doi: 10.1038/s41586-022-05487-2
            93.  Sulli G, Rommel A, Wang X,  et al. Pharmacological
               activation of REV-ERBs is lethal in cancer and oncogene-  104. Ramaswamy V, Remke M, Bouffet E, et al. Risk stratification
               induced senescence. Nature. 2018;553(7688):351-355.  of childhood medulloblastoma in the molecular era: The
                                                                  current consensus. Acta Neuropathol. 2016;131(6):821-831.
               doi: 10.1038/nature25170
                                                                  doi: 10.1007/s00401-016-1569-6
            94.  Nakashima A,  Kawamoto T, Honda KK,  et al. DEC1
               modulates the circadian phase of clock gene expression. Mol   105. Williamson D, Schwalbe EC, Hicks D, et al. Medulloblastoma
               Cell Biol. 2008;28(12):4080-4092.                  group 3 and 4 tumors comprise a clinically and biologically
                                                                  significant expression continuum reflecting human
               doi: 10.1128/MCB.02168-07
                                                                  cerebellar development. Cell Rep. 2022;40(5):111162.
            95.  Wu Y, Sato F, Yamada T, et al. The BHLH transcription factor
               DEC1  plays  an  important  role  in  the  epithelial-mesenchymal      doi: 10.1016/j.celrep.2022.111162
               transition of pancreatic cancer. Int J Oncol. 2012;41(4):1337-1346.  106. Tao R, Han K, Wu SC, Friske JD, Roussel MF, Northcott PA.
                                                                  Arrested development: The dysfunctional life history of
               doi: 10.3892/ijo.2012.1559
                                                                  medulloblastoma. Genes Dev. 2025;39:4-17.
            96.  Xiong J, Yang H, Luo W,  et al. The anti-metastatic effect
               of 8-MOP on hepatocellular carcinoma is potentiated by      doi: 10.1101/gad.351936.124
               the down-regulation of bHLH transcription factor DEC1.   107. Van Ommeren R, Garzia L, Holgado BL, Ramaswamy V,
               Pharmacol Res. 2016;105:121-133.                   Taylor MD. The molecular biology of medulloblastoma
                                                                  metastasis. Brain Pathol. 2020;30(3):691-702.
               doi: 10.1016/j.phrs.2016.01.025
                                                                  doi: 10.1111/bpa.12811
            97.  Cheng AH, Bouchard-Cannon P, Hegazi S,  et al. SOX2-
               dependent  transcription  in  clock  neurons  promotes   108. Paul  MR, Zage PE.  Overview and recent  advances  in the
               the  robustness  of  the  central  circadian  pacemaker.  Cell   targeting of medulloblastoma cancer stem cells. Expert Rev
               Rep. 2019;26(12):3191-3202.e8.                     Anticancer Ther. 2021;21(9):957-974.
               doi: 10.1016/j.celrep.2019.02.068                  doi: 10.1080/14737140.2021.1932472
            98.  Xie  XP, Ganbold M, Li  J,  et al. Glioblastoma  functional   109. Freire NH, Jaeger MDC, de Farias CB, et al. Targeting the
               heterogeneity and enrichment of cancer stem cells with   epigenome of cancer stem cells in pediatric nervous system
               tumor recurrence. Neuron. 2024;112(24):4017-4032.e6.  tumors. Mol Cell Biochem. 2023;478(10):2241-2255.
               doi: 10.1016/j.neuron.2024.10.012                  doi: 10.1007/s11010-022-04655-2
            99.  De A, Beligala DH, Sharma VP, Burgos CA, Lee AM,   110. Pachocki CJ, Hol EM. Current perspectives on diffuse
               Geusz ME. Cancer stem cell generation during epithelial-  midline glioma and a different role for the immune
               mesenchymal transition is  temporally gated  by intrinsic   microenvironment  compared  to  glioblastoma.
               circadian clocks. Clin Exp Metastasis. 2020;37(5):617-635.  J Neuroinflamm. 2022;19(1):276.
               doi: 10.1007/s10585-020-10051-1                    doi: 10.1186/s12974-022-02630-8
            100. Huang P, Guo YD, Zhang HW. Identification of Hub genes in   111. Kojima S, Sher-Chen EL, Green CB. Circadian control
               pediatric medulloblastoma by multiple-microarray analysis.   of mRNA polyadenylation dynamics regulates rhythmic
               J Mol Neurosci. 2020;70(4):522-531.                protein expression. Genes Dev. 2012;26(24):2724-2736.
               doi: 10.1007/s12031-019-01451-4                    doi: 10.1101/gad.208306.112



            Volume 4 Issue 2 (2025)                         23                               doi: 10.36922/gpd.4112
   124   125   126   127   128   129   130   131   132   133   134